In syngeneic mice models, supplementary IL-18 administration suppressed the growth of Meth A sarcoma and mouse glioma cells [7,8,9], suggesting that IL-18 plays an essential role in host mechanisms of defense against tumors. This evidence concerns the gene IL18 and central nervous system cancer.